Ajay C Gupta

US Patent:

7717859, May 18, 2010

Filed:

Dec 3, 2003

Appl. No.:

10/725393

Inventors:

Ajay Gupta - Cerritos CA, US

Assignee:

Applied Medical Technologies LLC. - Cerritos CA

International Classification:

A61B 5/00

US Classification:

600552

Abstract:

A combination electronic communication and medical diagnostic apparatus includes a first component for transmitting or receiving a remote communication signal and a second component for generating vibration to be used in a medical diagnosis. The apparatus functions as a beeper/pager or cellular phone, as well as a medical diagnostic tool to detect and/or monitor neuropathy.

US Patent:

8187467, May 29, 2012

Filed:

Dec 30, 2004

Appl. No.:

11/028114

Inventors:

Ajay Gupta - Cerritos CA, US

International Classification:

A61K 33/42
B01D 61/26
B01D 61/24

US Classification:

210647, 210646, 210645, 424601, 424603

Abstract:

Phosphate depletion, a physiological condition commonly seen in certain patient populations, including alcoholics, malnourished, acutely ill patients, patients receiving parenteral nutrition, patients being re-fed after prolonged fasting, and dialysis patients, requires intravenous supplementation when oral repletion is not feasible. This invention provides a method and pharmaceutical composition for therapeutic administration of pyrophosphate, instead of phosphate, for phosphate or pyrophosphate repletion. During hemodialysis or peritoneal dialysis significant removal of phosphate and pyrophosphate occurs. Pyrophosphate depletion predisposes patients to vascular calcification. This invention further provides a method and pharmaceutical composition for therapeutic administration of pyrophosphate for phosphate or pyrophosphate repletion by addition of pyrophosphate to hemodialysis or peritoneal dialysis solutions.

US Patent:

8632683, Jan 21, 2014

Filed:

Feb 17, 2011

Appl. No.:

13/029359

Inventors:

Ajay Gupta - Cerritos CA, US

International Classification:

B01D 61/26
A61K 33/42

US Classification:

210647, 210646, 424601, 424603

Abstract:

A pharmaceutical composition for therapeutic administration of pyrophosphate for phosphate repletion may be in either liquid or solid form and may be usable as or usable for preparing a hemodialysis or peritoneal dialysis solution containing a pyrophosphate compound present in an amount that provides a concentration in the dialysis solution equivalent to an inorganic phosphorus concentration of at least 0. 5 mg per deciliter.

US Patent:

20040175431, Sep 9, 2004

Filed:

Mar 9, 2004

Appl. No.:

10/796942

Inventors:

Ajay Gupta - Cerritos CA, US

International Classification:

A61K033/42

US Classification:

424/604000

Abstract:

A method of administering iron to dialysis patients is accomplished by infusion of a noncolloidal ferric compound, soluble in hemodialysis or peritoneal dialysis solutions, by the process of dialysis. A pharmaceutical composition is provided consisting essentially of dialysis solution including a soluble noncolloidal ferric compound, preferably ferric pyrophosphate.

US Patent:

20060135497, Jun 22, 2006

Filed:

Dec 17, 2004

Appl. No.:

11/016674

Inventors:

Ajay Gupta - Cerritos CA, US

International Classification:

A61K 31/56

US Classification:

514171000

Abstract:

A combination therapy and co-therapy method for administering therapeutic doses of an aldosterone antagonist agent and a metolazone-related compound to a subject in need of treatment for hypertension, congestive heart failure, and chronic kidney disease are provided. A pharmaceutical composition comprising these therapeutic agents is also provided.

US Patent:

20070148259, Jun 28, 2007

Filed:

Dec 22, 2006

Appl. No.:

11/644527

Inventors:

Ajay Gupta - Cerritos CA, US

International Classification:

A61K 33/42
A61K 31/70

US Classification:

424604000, 514023000

Abstract:

Bioavailable iron-containing parenteral nutrition compositions are provided that are physico-chemically stable. Iron is present in the form of soluble ferric pyrophosphate. Methods of preparation and use of the compositions are provide, as well as kits.

US Patent:

20080113952, May 15, 2008

Filed:

Aug 30, 2007

Appl. No.:

11/847660

Inventors:

Ajay Gupta - Cerritos CA, US

International Classification:

A61K 31/58
A61K 31/4164

US Classification:

514171, 514396

Abstract:

A combination therapy and co-therapy method for administering therapeutic doses of an aldosterone antagonist agent and a metolazone-related compound to a subject in need of treatment for hypertension, congestive heart failure, and chronic kidney disease are provided. A pharmaceutical composition comprising these therapeutic agents is also provided.

US Patent:

20090074883, Mar 19, 2009

Filed:

Sep 17, 2008

Appl. No.:

12/212391

Inventors:

Ajay Gupta - Cerritos CA, US

International Classification:

A61K 33/30
A61P 3/02

US Classification:

424643

Abstract:

The present invention relates to oral compositions which are useful for nutrient supplementation. The dietary supplements and pharmaceutical products and methods of the present invention are particularly useful in the treatment of patients in various stages of chronic kidney disease and supplementing levels of physiological anti-oxidants, vitamins, and minerals in subjects requiring dialysis therapy.